{"transactions":[{"id":725175,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:23:27.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045789","document":"wk-form4_1782505405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000162828026045789/wk-form4_1782505405.xml","form_type":"4"}},{"id":725335,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:21:41.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045784","document":"wk-form4_1782505299.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000162828026045784/wk-form4_1782505299.xml","form_type":"4"}},{"id":725559,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:21:00.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045780","document":"wk-form4_1782505258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000162828026045780/wk-form4_1782505258.xml","form_type":"4"}},{"id":725225,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35091,"kind":"person","name":"Smith Karen L.","position":1,"cik":"0001639637","reported_name":"Smith Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:20:18.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045778","document":"wk-form4_1782505215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639637/000162828026045778/wk-form4_1782505215.xml","form_type":"4"}},{"id":725519,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35157,"kind":"person","name":"Walker Luke Nathaniel","position":1,"cik":"0001701440","reported_name":"Walker Luke Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:19:39.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045775","document":"wk-form4_1782505176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701440/000162828026045775/wk-form4_1782505176.xml","form_type":"4"}},{"id":725619,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35193,"kind":"person","name":"Kantoff Philip W.","position":1,"cik":"0001866025","reported_name":"Kantoff Philip W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:13:50.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":0.576,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001628280-26-045762","document":"wk-form4_1782504828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866025/000162828026045762/wk-form4_1782504828.xml","form_type":"4"}},{"id":887417,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65119,"kind":"person","name":"Chagin Karen Deborah","position":1,"cik":"0002070710","reported_name":"Chagin Karen Deborah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-23T21:18:52.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":290000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001628280-26-010637","document":"wk-form4_1771881526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842952/000162828026010637/wk-form4_1771881526.xml","form_type":"4"}},{"id":888239,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-23T16:24:53.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":270000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001628280-26-010660","document":"wk-form4_1771881890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000162828026010660/wk-form4_1771881890.xml","form_type":"4"}},{"id":888963,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-23T16:21:41.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":275000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001628280-26-010642","document":"wk-form4_1771881698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000162828026010642/wk-form4_1771881698.xml","form_type":"4"}},{"id":888238,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-23T16:13:57.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":815000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":815000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":815000},"source":{"system":"sec-edgar","filing":"0001628280-26-010616","document":"wk-form4_1771881235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000162828026010616/wk-form4_1771881235.xml","form_type":"4"}},{"id":1112802,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:30:09.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":138900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":138900,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":138900},"source":{"system":"sec-edgar","filing":"0001842952-25-000078","document":"wk-form4_1749763803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000184295225000078/wk-form4_1749763803.xml","form_type":"4"}},{"id":1113677,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35193,"kind":"person","name":"Kantoff Philip W.","position":1,"cik":"0001866025","reported_name":"Kantoff Philip W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:28:39.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000077","document":"wk-form4_1749763711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866025/000184295225000077/wk-form4_1749763711.xml","form_type":"4"}},{"id":1112866,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35091,"kind":"person","name":"Smith Karen L.","position":1,"cik":"0001639637","reported_name":"Smith Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:27:03.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000076","document":"wk-form4_1749763615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639637/000184295225000076/wk-form4_1749763615.xml","form_type":"4"}},{"id":1113028,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:25:54.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000075","document":"wk-form4_1749763548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295225000075/wk-form4_1749763548.xml","form_type":"4"}},{"id":1113452,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35157,"kind":"person","name":"Walker Luke Nathaniel","position":1,"cik":"0001701440","reported_name":"Walker Luke Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:24:53.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000074","document":"wk-form4_1749763486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701440/000184295225000074/wk-form4_1749763486.xml","form_type":"4"}},{"id":1113578,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T21:23:33.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":123500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":123500,"derivative":{"exercise_price":0.653,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":123500},"source":{"system":"sec-edgar","filing":"0001842952-25-000073","document":"wk-form4_1749763407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295225000073/wk-form4_1749763407.xml","form_type":"4"}},{"id":1116471,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-10T17:26:21.000Z","date":"2025-06-09","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.7008,"value":70080.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":920190,"source":{"system":"sec-edgar","filing":"0001842952-25-000064","document":"wk-form4_1749590774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295225000064/wk-form4_1749590774.xml","form_type":"4"}},{"id":1116472,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Common Stock","published_at":"2025-06-10T17:23:47.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.576,"value":11520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.56 - $0.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001842952-25-000062","document":"wk-form4_1749590621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000184295225000062/wk-form4_1749590621.xml","form_type":"4"}},{"id":1116888,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T17:22:20.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":40010,"price":0.637,"value":25486.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":80010,"source":{"system":"sec-edgar","filing":"0001842952-25-000060","document":"wk-form4_1749590535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295225000060/wk-form4_1749590535.xml","form_type":"4"}},{"id":1117206,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65119,"kind":"person","name":"Chagin Karen Deborah","position":1,"cik":"0002070710","reported_name":"Chagin Karen Deborah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T21:22:17.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":153000,"derivative":{"exercise_price":0.703,"expiration_date":"2035-06-08","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001842952-25-000056","document":"wk-form4_1749504091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842952/000184295225000056/wk-form4_1749504091.xml","form_type":"4"}},{"id":1268210,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:13:21.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":371800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":371800,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":371800},"source":{"system":"sec-edgar","filing":"0001842952-25-000022","document":"wk-form4_1739567592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295225000022/wk-form4_1739567592.xml","form_type":"4"}},{"id":1267576,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:11:55.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":349900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":349900,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":349900},"source":{"system":"sec-edgar","filing":"0001842952-25-000021","document":"wk-form4_1739567504.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000184295225000021/wk-form4_1739567504.xml","form_type":"4"}},{"id":1267752,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":83205,"kind":"person","name":"Dansky Ullmann Claudio","position":1,"cik":"0002030789","reported_name":"Dansky Ullmann Claudio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:07:37.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":174960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":174960,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":174960},"source":{"system":"sec-edgar","filing":"0001842952-25-000020","document":"wk-form4_1739567246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030789/000184295225000020/wk-form4_1739567246.xml","form_type":"4"}},{"id":1267575,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:06:32.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":802700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":802700,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":802700},"source":{"system":"sec-edgar","filing":"0001842952-25-000019","document":"wk-form4_1739567178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295225000019/wk-form4_1739567178.xml","form_type":"4"}},{"id":1303120,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35071,"kind":"person","name":"Pasternak Andy","position":1,"cik":"0001792746","reported_name":"Pasternak Andy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-15T01:43:51.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":20685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":20685,"derivative":{"exercise_price":1.03,"expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":20685},"source":{"system":"sec-edgar","filing":"0001842952-25-000010","document":"wk-form4_1736905424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1792746/000184295225000010/wk-form4_1736905424.xml","form_type":"4"}},{"id":1413486,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35091,"kind":"person","name":"Smith Karen L.","position":1,"cik":"0001639637","reported_name":"Smith Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T12:15:04.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":19315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":19315,"derivative":{"exercise_price":2.43,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":19315},"source":{"system":"sec-edgar","filing":"0001842952-24-000079","document":"wk-form4_1725538497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1639637/000184295224000079/wk-form4_1725538497.xml","form_type":"4"}},{"id":1413980,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35157,"kind":"person","name":"Walker Luke Nathaniel","position":1,"cik":"0001701440","reported_name":"Walker Luke Nathaniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T12:04:53.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":19315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":19315,"derivative":{"exercise_price":2.43,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":19315},"source":{"system":"sec-edgar","filing":"0001842952-24-000077","document":"wk-form4_1725537887.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701440/000184295224000077/wk-form4_1725537887.xml","form_type":"4"}},{"id":1444465,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":83205,"kind":"person","name":"Dansky Ullmann Claudio","position":1,"cik":"0002030789","reported_name":"Dansky Ullmann Claudio","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-01T17:18:30.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":202170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on August 1, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":202170,"derivative":{"exercise_price":2.23,"expiration_date":"2034-07-31","underlying":"Common Stock","underlying_shares":202170},"source":{"system":"sec-edgar","filing":"0001842952-24-000062","document":"wk-form4_1722547103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030789/000184295224000062/wk-form4_1722547103.xml","form_type":"4"}},{"id":1478689,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T11:52:58.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.97,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-24-000048","document":"wk-form4_1718365971.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295224000048/wk-form4_1718365971.xml","form_type":"4"}},{"id":1479334,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35193,"kind":"person","name":"Kantoff Philip W.","position":1,"cik":"0001866025","reported_name":"Kantoff Philip W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T11:50:14.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.97,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-24-000046","document":"wk-form4_1718365807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866025/000184295224000046/wk-form4_1718365807.xml","form_type":"4"}},{"id":1479146,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T11:47:03.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.97,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-24-000044","document":"wk-form4_1718365616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295224000044/wk-form4_1718365616.xml","form_type":"4"}},{"id":1479556,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T07:41:42.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.97,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001842952-24-000042","document":"wk-form4_1718365295.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000184295224000042/wk-form4_1718365295.xml","form_type":"4"}},{"id":1564114,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T08:04:35.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":160115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":160115,"derivative":{"exercise_price":1.07,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":160115},"source":{"system":"sec-edgar","filing":"0001842952-24-000019","document":"wk-form4_1711109066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295224000019/wk-form4_1711109066.xml","form_type":"4"}},{"id":1563569,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T08:01:46.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":153515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":153515,"derivative":{"exercise_price":1.07,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":153515},"source":{"system":"sec-edgar","filing":"0001842952-24-000018","document":"wk-form4_1711108898.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000184295224000018/wk-form4_1711108898.xml","form_type":"4"}},{"id":1563566,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T08:01:08.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":291402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":291402,"derivative":{"exercise_price":1.07,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":291402},"source":{"system":"sec-edgar","filing":"0001842952-24-000017","document":"wk-form4_1711108859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295224000017/wk-form4_1711108859.xml","form_type":"4"}},{"id":1873482,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35193,"kind":"person","name":"Kantoff Philip W.","position":1,"cik":"0001866025","reported_name":"Kantoff Philip W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-31T20:53:47.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-23-000062","document":"wf-form4_168556641370866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866025/000184295223000062/wf-form4_168556641370866.xml","form_type":"4"}},{"id":1873405,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-31T20:53:30.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-23-000061","document":"wf-form4_168556639644192.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295223000061/wf-form4_168556639644192.xml","form_type":"4"}},{"id":1873208,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-31T20:53:12.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-23-000060","document":"wf-form4_168556637918497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295223000060/wf-form4_168556637918497.xml","form_type":"4"}},{"id":1873589,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-31T16:52:56.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001842952-23-000059","document":"wf-form4_168556636136177.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000184295223000059/wf-form4_168556636136177.xml","form_type":"4"}},{"id":2003838,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-21T20:05:37.000Z","date":"2023-02-21","kind":"purchase","acquired":true,"shares":5823,"price":0.8415,"value":4900.0545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8154 - $0.8470. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":159701,"source":{"system":"sec-edgar","filing":"0001842952-23-000030","document":"wf-form4_167702790361209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000030/wf-form4_167702790361209.xml","form_type":"4"}},{"id":2016871,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-14T17:04:47.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":151505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":151505,"derivative":{"exercise_price":0.8407,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":151505},"source":{"system":"sec-edgar","filing":"0001842952-23-000028","document":"wf-form4_167641226007313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000184295223000028/wf-form4_167641226007313.xml","form_type":"4"}},{"id":2016864,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-14T17:04:39.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":287544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":287544,"derivative":{"exercise_price":0.8407,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":287544},"source":{"system":"sec-edgar","filing":"0001842952-23-000027","document":"wf-form4_167641224437732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000027/wf-form4_167641224437732.xml","form_type":"4"}},{"id":2017626,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-14T17:04:29.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":158001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":158001,"derivative":{"exercise_price":0.8407,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":158001},"source":{"system":"sec-edgar","filing":"0001842952-23-000026","document":"wf-form4_167641222454214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295223000026/wf-form4_167641222454214.xml","form_type":"4"}},{"id":2020252,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-13T16:03:23.000Z","date":"2023-02-13","kind":"purchase","acquired":true,"shares":5606,"price":0.8742,"value":4900.7652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8563 - $0.8938. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":153878,"source":{"system":"sec-edgar","filing":"0001842952-23-000020","document":"wf-form4_167632218722654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000020/wf-form4_167632218722654.xml","form_type":"4"}},{"id":2030814,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-06T16:03:09.000Z","date":"2023-02-06","kind":"purchase","acquired":true,"shares":5040,"price":0.9723,"value":4900.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.9449 - $1.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":148272,"source":{"system":"sec-edgar","filing":"0001842952-23-000017","document":"wf-form4_167571737374433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000017/wf-form4_167571737374433.xml","form_type":"4"}},{"id":2042352,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T16:03:31.000Z","date":"2023-01-30","kind":"purchase","acquired":true,"shares":7027,"price":0.6974,"value":4900.6298,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.682 - $0.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":143232,"source":{"system":"sec-edgar","filing":"0001842952-23-000012","document":"wf-form4_167511259579472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000012/wf-form4_167511259579472.xml","form_type":"4"}},{"id":2048801,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-23T17:03:22.000Z","date":"2023-01-23","kind":"purchase","acquired":true,"shares":6839,"price":0.7166,"value":4900.8274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.7052 - $0.7251. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":136205,"source":{"system":"sec-edgar","filing":"0001842952-23-000008","document":"wf-form4_167451138827052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000008/wf-form4_167451138827052.xml","form_type":"4"}},{"id":2052698,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-18T16:04:19.000Z","date":"2023-01-17","kind":"purchase","acquired":true,"shares":6783,"price":0.7364,"value":4995.0012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average purchase price. These shares were acquired in several transactions at prices ranging from $0.7298 - $0.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":129366,"source":{"system":"sec-edgar","filing":"0001842952-23-000006","document":"wf-form4_167407584583579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000006/wf-form4_167407584583579.xml","form_type":"4"}},{"id":2082521,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-19T16:22:43.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":25000,"price":0.74,"value":18500.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001842952-22-000114","document":"wf-form4_167148450192465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295222000114/wf-form4_167148450192465.xml","form_type":"4"}},{"id":2081960,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-19T16:11:16.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":20000,"price":0.7398,"value":14796.0,"ownership":{"direct":true},"balance_after":122583,"source":{"system":"sec-edgar","filing":"0001842952-22-000112","document":"wf-form4_167148401293928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295222000112/wf-form4_167148401293928.xml","form_type":"4"}},{"id":2089903,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Common Stock","published_at":"2022-12-12T16:15:07.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":6000,"price":0.8491,"value":5094.6,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001842952-22-000110","document":"wf-form4_167087968272097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000184295222000110/wf-form4_167087968272097.xml","form_type":"4"}},{"id":2177087,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-22T16:04:09.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":13000,"price":1.8511,"value":24064.3,"ownership":{"direct":true},"balance_after":102583,"source":{"system":"sec-edgar","filing":"0001842952-22-000081","document":"wf-form4_166119862135485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295222000081/wf-form4_166119862135485.xml","form_type":"4"}},{"id":2182675,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-17T17:23:58.000Z","date":"2022-08-17","kind":"purchase","acquired":true,"shares":15000,"price":1.8,"value":27000.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001842952-22-000079","document":"wf-form4_166077142478085.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295222000079/wf-form4_166077142478085.xml","form_type":"4"}},{"id":2182073,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":124489,"kind":"person","name":"Sahmoud Tarek","position":1,"cik":"0001861811","reported_name":"Sahmoud Tarek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-08-17T17:22:47.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":10000,"price":1.95,"value":19500.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001842952-22-000077","document":"wf-form4_166077134963058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861811/000184295222000077/wf-form4_166077134963058.xml","form_type":"4"}},{"id":2187078,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":124489,"kind":"person","name":"Sahmoud Tarek","position":1,"cik":"0001861811","reported_name":"Sahmoud Tarek","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-12T16:31:15.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.96,"expiration_date":"2032-08-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-22-000075","document":"wf-form4_166033625278582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861811/000184295222000075/wf-form4_166033625278582.xml","form_type":"4"}},{"id":2244989,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35164,"kind":"person","name":"West Linda","position":1,"cik":"0001805257","reported_name":"West Linda","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:10:59.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":2.19,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-22-000060","document":"wf-form4_165428703516071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805257/000184295222000060/wf-form4_165428703516071.xml","form_type":"4"}},{"id":2245203,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":35193,"kind":"person","name":"Kantoff Philip W.","position":1,"cik":"0001866025","reported_name":"Kantoff Philip W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:10:28.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":2.19,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-22-000059","document":"wf-form4_165428700930146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866025/000184295222000059/wf-form4_165428700930146.xml","form_type":"4"}},{"id":2244027,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":23556,"kind":"person","name":"Stacey Jennifer Evans","position":1,"cik":"0001321326","reported_name":"Stacey Jennifer Evans","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:09:13.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":2.19,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001842952-22-000057","document":"wf-form4_165428693172276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321326/000184295222000057/wf-form4_165428693172276.xml","form_type":"4"}},{"id":2245520,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":84354,"kind":"person","name":"BERMAN RICHARD J","position":1,"cik":"0001111620","reported_name":"BERMAN RICHARD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T16:09:54.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":2.19,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001842952-22-000058","document":"wf-form4_165428696068442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111620/000184295222000058/wf-form4_165428696068442.xml","form_type":"4"}},{"id":2372541,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-25T16:43:19.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":107870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":107870,"derivative":{"exercise_price":1.79,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":107870},"source":{"system":"sec-edgar","filing":"0001842952-22-000022","document":"wf-form4_164582536740296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000184295222000022/wf-form4_164582536740296.xml","form_type":"4"}},{"id":2372992,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-25T16:42:41.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":112470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":112470,"derivative":{"exercise_price":1.79,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":112470},"source":{"system":"sec-edgar","filing":"0001842952-22-000021","document":"wf-form4_164582531007999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295222000021/wf-form4_164582531007999.xml","form_type":"4"}},{"id":2372429,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-25T16:38:36.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":254300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":254300,"derivative":{"exercise_price":1.79,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":254300},"source":{"system":"sec-edgar","filing":"0001842952-22-000018","document":"wf-form4_164582507420064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295222000018/wf-form4_164582507420064.xml","form_type":"4"}},{"id":2388856,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Section 16 officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-17T16:56:48.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":29223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments with 1/13th vesting on the last day of the calendar month in which the grant occurs and 1/13th on the last day of each subsequent month until fully vested on February 28, 2023. Additionally, 29,225 previously granted but unvested restricted stock units were cancelled as of December 30, 2021."}],"balance_after":29223,"derivative":{"exercise_price":2.05,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001842952-22-000016","document":"wf-form4_164513498176142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000184295222000016/wf-form4_164513498176142.xml","form_type":"4"}},{"id":2389934,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130304,"kind":"person","name":"Rencher William F.","position":1,"cik":"0001865206","reported_name":"Rencher William F.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Section 16 officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-17T16:48:55.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal installments with 1/10th vesting on the date of this grant and each grant thereafter occurring on the last day of each calendar month until fully vested on October 31, 2022."}],"balance_after":8000,"derivative":{"exercise_price":2.05,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001842952-22-000014","document":"wf-form4_164513451665299.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865206/000184295222000014/wf-form4_164513451665299.xml","form_type":"4"}},{"id":2464131,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-20T16:02:00.000Z","date":"2021-12-16","kind":"purchase","acquired":true,"shares":13000,"price":3.2192,"value":41849.6,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":820190,"source":{"system":"sec-edgar","filing":"0001842952-21-000029","document":"wf-form4_164003409890044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000029/wf-form4_164003409890044.xml","form_type":"4"}},{"id":2466637,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed Preferred Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":586475,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":1,"derivative":{"underlying":"Common Stock","underlying_shares":586475},"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466636,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":210715,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":7,"derivative":{"underlying":"Common Stock","underlying_shares":210715},"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466635,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":0,"derivative":{"exercise_price":7.14,"exercise_date":"2020-12-20","expiration_date":"2030-12-20","underlying":"Common Stock","underlying_shares":52680},"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466634,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":807190,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466633,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":586475,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":797190,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466632,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":210715,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":210715,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466631,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":7.14,"value":376135.2,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466639,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Series Seed Preferred Stock","published_at":"2021-12-17T16:12:39.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26587},"source":{"system":"sec-edgar","filing":"0001842952-21-000025","document":"wf-form4a_163977554088927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000184295221000025/wf-form4a_163977554088927.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466638,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Common Stock","published_at":"2021-12-17T16:12:39.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,397 restricted stock units which fully vest on January 31, 2023."}],"balance_after":82960,"source":{"system":"sec-edgar","filing":"0001842952-21-000025","document":"wf-form4a_163977554088927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000184295221000025/wf-form4a_163977554088927.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2531074,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65257,"kind":"person","name":"Minai-Azary Jennifer Lynn","position":1,"cik":"0001844398","reported_name":"Minai-Azary Jennifer Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-01T16:31:17.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":52753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests each month (1/36 each month) from the date of the grant, November 1, 2021"}],"balance_after":52753,"derivative":{"exercise_price":5.59,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":52753},"source":{"system":"sec-edgar","filing":"0001842952-21-000009","document":"wf-form4_163579861906118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1844398/000184295221000009/wf-form4_163579861906118.xml","form_type":"4"}},{"id":2535673,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65194,"kind":"person","name":"Levit Alex C.","position":1,"cik":"0001862840","reported_name":"Levit Alex C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer, Corp. Sec"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:36.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":3000,"price":5,"value":15000.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001179110-21-009610","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862840/000117911021009610/edgar.xml","form_type":"4"}},{"id":2535670,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed Preferred Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":586476,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":586476},"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535669,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":210722,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":210722},"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535668,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":0,"derivative":{"exercise_price":7.14,"exercise_date":"2020-12-20","expiration_date":"2030-12-20","underlying":"Common Stock","underlying_shares":52680},"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535667,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":586476,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":849878,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535666,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":210722,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":263402,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535665,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":7.14,"value":376135.2,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":52680,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535664,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":true},"balance_after":99583,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535672,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Series Seed Preferred Stock","published_at":"2021-10-25T17:29:56.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26587},"source":{"system":"sec-edgar","filing":"0001179110-21-009608","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000117911021009608/edgar.xml","form_type":"4"}},{"id":2535671,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":130283,"kind":"person","name":"Dick Evan G.","position":1,"cik":"0001862116","reported_name":"Dick Evan G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of R&D"}}],"security":"Common Stock","published_at":"2021-10-25T17:29:56.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":26587,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39,659 restricted stock units which fully vest on February 24, 2023."}],"balance_after":87139,"source":{"system":"sec-edgar","filing":"0001179110-21-009608","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862116/000117911021009608/edgar.xml","form_type":"4"}}]}